The launch of the compounded pill was met with a renewed lawsuit against Hims & Hers by the brand manufacturer for allegations of intellectual property infringement, and a notice from the HHS Office of General Counsel that it had referred the matter to the US Department of Justice (DOJ) for investigation
Recent studies, adverse event data, and ongoing litigation indicate a potential connection between ozempic and vision loss , particularly a condition known as: NAION (non-arteritic anterior ischemic optic neuropathy) is a serious eye condition caused by reduced blood flow to the optic nerve
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
It differs from other groups of oral hypoglycemic agents as it does not result in hypoglycemia or hyperinsulinemia
As of the time of writing, retatrutide is not licensed or approved for use in the United Kingdom
